{"transactions":[{"id":810622,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":52936,"kind":"person","name":"Warren Lucinda","position":1,"cik":"0002035620","reported_name":"Warren Lucinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-10T20:00:05.000Z","date":"2026-04-09","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable over four years, with 25% vesting on the one year anniversary of the grant date and the remainder vesting in equal, semi-annual installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":0.29,"expiration_date":"2036-04-08","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001193125-26-151201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035620/000119312526151201/ownership.xml","form_type":"4"}},{"id":988938,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":52936,"kind":"person","name":"Warren Lucinda","position":1,"cik":"0002035620","reported_name":"Warren Lucinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T21:00:05.000Z","date":"2025-09-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes fully exercisable on the first anniversary of the grant date."}],"balance_after":125000,"derivative":{"exercise_price":0.72,"expiration_date":"2035-09-28","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193125-25-296986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035620/000119312525296986/ownership.xml","form_type":"4"}},{"id":1192453,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":52936,"kind":"person","name":"Warren Lucinda","position":1,"cik":"0002035620","reported_name":"Warren Lucinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-25T20:00:05.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025."}],"balance_after":250000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-25-044344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035620/000095017025044344/ownership.xml","form_type":"4"}},{"id":1414251,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":52936,"kind":"person","name":"Warren Lucinda","position":1,"cik":"0002035620","reported_name":"Warren Lucinda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:00:02.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in four equal semi-annual installments beginning on March 3, 2025."}],"balance_after":350000,"derivative":{"exercise_price":0.66,"expiration_date":"2034-09-02","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000950170-24-103955","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035620/000095017024103955/ownership.xml","form_type":"4"}}]}